🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this interventional clinical trial is to compare patients who u...
Status
Recruiting
Location
University Hospital Tuebingen
Start Date
2023-01-01
Trial ID
NCT05640635
Treatments Being Tested
Rationale: In patients supported with extracorporeal membrane oxygenation (...
Status
Recruiting
Location
MedUni Wien
Start Date
2024-11-26
Trial ID
NCT06560164
Treatments Being Tested
Peripheral Veno-Arterial Extra Corporeal Membrane Oxygenation (VA ECMO) is ...
Status
Unknown
Location
Uhmontpellier
Start Date
2020-02-01
Trial ID
NCT04984603
Treatments Being Tested
Leronlimab (PRO 140) is a humanized IgG4,k monoclonal antibody (mAb) that r...
Status
Suspended
Location
Hospital Dr Jayme dos Santos Neves
Start Date
2021-10-23
Trial ID
NCT04901689
Treatments Being Tested
The aim of this study is to characterize ventilation/perfusion (V/Q) matchi...
Status
Enrolling By Invitation
Location
Beth Israel Deaconess Medical Center
Start Date
2026-01-27
Trial ID
NCT07141524
Treatments Being Tested
The primary objective of this work is to study the 1-year prognosis of pati...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-20
Trial ID
NCT05696210
Treatments Being Tested
Thrombocytopenia is a frequent and serious adverse event in patients treate...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-01
Trial ID
NCT03979625
The PROTECT-EU Registry is a prospective, non-randomized, multi-national re...
Status
Unknown
Location
Ospedale San Raffaele
Start Date
2022-10-18
Trial ID
NCT05466552
Treatments Being Tested
The Acute Respiratory Distress Syndrome (ARDS) is defined by a recent (with...
Status
Unknown
Location
Federico Longhini
Start Date
2022-02-01
Trial ID
NCT05198986
Treatments Being Tested
The most frequent access site for veno-arterial extracorporeal membrane oxy...
Status
Unknown
Location
Multiple Locations
Start Date
2021-02-01
Trial ID
NCT04689451